BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24040178)

  • 21. Pregabalin for the treatment of fibromyalgia.
    Smith MT; Moore BJ
    Expert Opin Pharmacother; 2012 Jul; 13(10):1527-33. PubMed ID: 22725707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial.
    Gilron I; Chaparro LE; Tu D; Holden RR; Milev R; Towheed T; DuMerton-Shore D; Walker S
    Pain; 2016 Jul; 157(7):1532-40. PubMed ID: 26982602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of a Novel form of Extended-Release Gabapentin on Pain and Sleep in Fibromyalgia Subjects: An Open-Label Pilot Study.
    North JM; Hong KS; Rauck RL
    Pain Pract; 2016 Jul; 16(6):720-9. PubMed ID: 26059271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prior Opioid Use Does Not Impact the Response to Pregabalin in Patients With Fibromyalgia.
    Argoff CE; Clair A; Emir B; Whalen E; Ortiz M; Pauer L
    Clin J Pain; 2016 Jul; 32(7):555-61. PubMed ID: 25756560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports.
    Straube S; Derry S; Moore RA; McQuay HJ
    Rheumatology (Oxford); 2010 Apr; 49(4):706-15. PubMed ID: 20056767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalin.
    Arnold LM; Zlateva G; Sadosky A; Emir B; Whalen E
    Pain Med; 2011 Feb; 12(2):260-7. PubMed ID: 21266008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregabalin as treatment for fibromyalgia: the rest of the story?
    Holman AJ
    Curr Pain Headache Rep; 2009 Dec; 13(6):420-2. PubMed ID: 19889281
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia.
    Arnold LM; Crofford LJ; Martin SA; Young JP; Sharma U
    Pain Med; 2007; 8(8):633-8. PubMed ID: 18028041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial.
    Bidari A; Moazen-Zadeh E; Ghavidel-Parsa B; Rahmani S; Hosseini S; Hassankhani A
    Daru; 2019 Jun; 27(1):149-158. PubMed ID: 30877484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Baseline Characteristics on the Pain Response to Pregabalin in Fibromyalgia Patients with Comorbid Depression.
    Silverman SL; Backonja M; Pauer L; Landen J; Bhadra Brown P; Scavone JM; Vissing R; Clair A
    Pain Med; 2018 Mar; 19(3):419-428. PubMed ID: 28525632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregabalin: a treatment for fibromyalgia and other painful conditions.
    Smith SM
    Nurs Womens Health; 2008 Oct; 12(5):432-5. PubMed ID: 18837723
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment response to pregabalin in fibromyalgia pain: effect of patient baseline characteristics.
    Emir B; Murphy TK; Petersel DL; Whalen E
    Expert Opin Pharmacother; 2010 Oct; 11(14):2275-80. PubMed ID: 20812879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy of fibromyalgia.
    Mease PJ; Dundon K; Sarzi-Puttini P
    Best Pract Res Clin Rheumatol; 2011 Apr; 25(2):285-97. PubMed ID: 22094202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.
    Arnold LM; Emir B; Murphy TK; Zeiher BG; Pauer L; Scott G; Petersel D
    Clin Ther; 2012 May; 34(5):1092-102. PubMed ID: 22503162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of pregabalin as a monotherapy versus combined pregabalin and milnacipran in the management of fibromyalgia.
    Abdel Fattah YH; Elnemr R
    Int J Rheum Dis; 2020 Nov; 23(11):1474-1480. PubMed ID: 32886447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards a neurophysiological signature for fibromyalgia.
    López-Solà M; Woo CW; Pujol J; Deus J; Harrison BJ; Monfort J; Wager TD
    Pain; 2017 Jan; 158(1):34-47. PubMed ID: 27583567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticonvulsants for fibromyalgia.
    Üçeyler N; Sommer C; Walitt B; Häuser W
    Cochrane Database Syst Rev; 2013 Oct; (10):CD010782. PubMed ID: 24129853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study.
    Roth T; Lankford DA; Bhadra P; Whalen E; Resnick EM
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):597-606. PubMed ID: 22232085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Comorbid Depression Taking Concurrent Antidepressant Medication: A Randomized, Placebo-controlled Study.
    Arnold LM; Sarzi-Puttini P; Arsenault P; Khan T; Bhadra Brown P; Clair A; Scavone JM; Driscoll J; Landen J; Pauer L
    J Rheumatol; 2015 Jul; 42(7):1237-44. PubMed ID: 26034150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal clinically important difference in the fibromyalgia impact questionnaire.
    Bennett RM; Bushmakin AG; Cappelleri JC; Zlateva G; Sadosky AB
    J Rheumatol; 2009 Jun; 36(6):1304-11. PubMed ID: 19369473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.